Loading...

Elissa Ozanne, PhD

TitleAssociate Professor
InstitutionUniversity of California San Francisco
DepartmentSurgery
Address3333 Calif. St,Laurel Heights
San Francisco CA 94118
Phone415-476-1942
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Evaluating a decision aid for breast cancer prevention: a pilot trial
    NIH/NCI R21CA141097Mar 1, 2010 - Feb 28, 2013
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Ozanne E, Karliner LS, Tice JA, Haas JS, Livaudais-Toman J, Pasick RJ, Kaplan CP. An Intervention Tool to Increase Patient-Physician Discussion of Lifestyle Risk Factors for Breast Cancer. J Womens Health (Larchmt). 2018 Sep 15. PMID: 30222505.
      View in: PubMed
    2. He X, Schifferdecker KE, Ozanne EM, Tosteson ANA, Woloshin S, Schwartz LM. How Do Women View Risk-Based Mammography Screening? A Qualitative Study. J Gen Intern Med. 2018 Jul 31. PMID: 30066118.
      View in: PubMed
    3. Stout NK, Cronin AM, Uno H, Ozanne EM, Hassett MJ, Frank ES, Greenberg CC, Punglia RS. Estrogen-receptor status and risk of contralateral breast cancer following DCIS. Breast Cancer Res Treat. 2018 Jun 26. PMID: 29946862.
      View in: PubMed
    4. Durand MA, Yen RW, O'Malley AJ, Politi MC, Dhage S, Rosenkranz K, Weichman K, Margenthaler J, Tosteson ANA, Crayton E, Jackson S, Bradley A, Volk RJ, Sepucha K, Ozanne E, Percac-Lima S, Song J, Acosta J, Mir N, Elwyn G. What matters most: protocol for a randomized controlled trial of breast cancer surgery encounter decision aids across socioeconomic strata. BMC Public Health. 2018 02 13; 18(1):241. PMID: 29439691.
      View in: PubMed
    5. Henderson LM, Hubbard RA, Zhu W, Weiss J, Wernli KJ, Goodrich ME, Kerlikowske K, DeMartini W, Ozanne EM, Onega T. Preoperative Breast Magnetic Resonance Imaging Use by Breast Density and Family History of Breast Cancer. J Womens Health (Larchmt). 2018 Jan 15. PMID: 29334616.
      View in: PubMed
    6. Onega T, Weiss JE, Goodrich ME, Zhu W, DeMartini WB, Kerlikowske K, Ozanne E, Tosteson ANA, Henderson LM, Buist DSM, Wernli KJ, Herschorn SD, Hotaling E, O'Donoghue C, Hubbard R. Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer. J Surg Oncol. 2017 Dec; 116(8):1008-1015. PMID: 29127715.
      View in: PubMed
    7. Lockwood R, Ozanne E, Hur C, Yachimski P. Patient decision-making and clinical outcomes following endoscopic therapy or esophagectomy for Barrett's neoplasia. Endosc Int Open. 2017 Nov; 5(11):E1128-E1135. PMID: 29124122.
      View in: PubMed
    8. Bickel K, Ozanne E. Reply to S.R. Isenberg et al. J Oncol Pract. 2017 Nov; 13(11):774-775. PMID: 28915076.
      View in: PubMed
    9. Forcino RC, Barr PJ, O'Malley AJ, Arend R, Castaldo MG, Ozanne EM, Percac-Lima S, Stults CD, Tai-Seale M, Thompson R, Elwyn G. Using CollaboRATE, a brief patient-reported measure of shared decision making: Results from three clinical settings in the United States. Health Expect. 2018 Feb; 21(1):82-89. PMID: 28678426.
      View in: PubMed
    10. Bickel K, Ozanne E. Importance of Costs and Cost Effectiveness of Palliative Care. J Oncol Pract. 2017 May; 13(5):287-289. PMID: 28437151.
      View in: PubMed
    11. Barr PJ, Forcino RC, Thompson R, Ozanne EM, Arend R, Castaldo MG, O'Malley AJ, Elwyn G. Evaluating CollaboRATE in a clinical setting: analysis of mode effects on scores, response rates and costs of data collection. BMJ Open. 2017 03 24; 7(3):e014681. PMID: 28341691.
      View in: PubMed
    12. Newhall K, Albright B, Tosteson A, Ozanne E, Trus T, Goodney PP. Cost-effectiveness of prophylactic appendectomy: a Markov model. Surg Endosc. 2017 Sep; 31(9):3596-3604. PMID: 28078461.
      View in: PubMed
    13. Punglia RS, Cronin AM, Uno H, Stout NK, Ozanne EM, Greenberg CC, Frank ES, Schrag D. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation. JAMA Oncol. 2017 Jan 01; 3(1):101-104. PMID: 27442038.
      View in: PubMed
    14. Ozanne EM, Weiss JE, Onega T, DeMartini W, Kerlikowske K, Buist DS, Henderson L, Hubbard RA, Goodrich M, Tosteson AN, Virnig BA, O'Donoghue C. Locoregional treatment of breast cancer in women with and without preoperative magnetic resonance imaging. Am J Surg. 2017 Jan; 213(1):132-139.e2. PMID: 27421187.
      View in: PubMed
    15. Cohan JN, Ozanne EM, Sewell JL, Hofer RK, Mahadevan U, Varma MG, Finlayson E. A Novel Decision Aid for Surgical Patients with Ulcerative Colitis: Results of a Pilot Study. Dis Colon Rectum. 2016 Jun; 59(6):520-8. PMID: 27145309.
      View in: PubMed
    16. Barnes AJ, Hanoch Y, Miron-Shatz T, Ozanne EM. Tailoring risk communication to improve comprehension: Do patient preferences help or hurt? Health Psychol. 2016 09; 35(9):1007-16. PMID: 27183307.
      View in: PubMed
    17. Barlow DR, Higgins BT, Ozanne EM, Tosteson AN, Pearson AM. Cost Effectiveness of Operative Versus Non-Operative Treatment of Geriatric Type-II Odontoid Fracture. Spine (Phila Pa 1976). 2016 Apr; 41(7):610-7. PMID: 27018900; PMCID: PMC4915371 [Available on 04/01/17].
    18. Ozanne EM, Schneider KH, Soeteman D, Stout N, Schrag D, Fordis M, Punglia RS. onlineDeCISion.org: a web-based decision aid for DCIS treatment. Breast Cancer Res Treat. 2015 Nov; 154(1):181-90. PMID: 26475704.
      View in: PubMed
    19. Winn K, Ozanne E, Sepucha K. Measuring patient-centered care: An updated systematic review of how studies define and report concordance between patients' preferences and medical treatments. Patient Educ Couns. 2015 Jul; 98(7):811-21. PMID: 25846191.
      View in: PubMed
    20. Barr PJ, Thompson R, Walsh T, Grande SW, Ozanne EM, Elwyn G. Correction: the psychometric properties of CollaboRATE: a fast and frugal patient-reported measure of the shared decision-making process. J Med Internet Res. 2015 Feb 06; 17(2):e32. PMID: 25667387; PMCID: PMC4353887.
    21. Howe R, Miron-Shatz T, Hanoch Y, Omer ZB, O'Donoghue C, Ozanne EM. Personalized Medicine Through SNP Testing for Breast Cancer Risk: Clinical Implementation. J Genet Couns. 2015 Oct; 24(5):744-51. PMID: 25519004.
      View in: PubMed
    22. Hanoch Y, Miron-Shatz T, Rolison JJ, Ozanne E. Understanding of BRCA1/2 genetic tests results: the importance of objective and subjective numeracy. Psychooncology. 2014 Oct; 23(10):1142-8. PMID: 24733657.
      View in: PubMed
    23. Yachimski P, Wani S, Givens T, Howard E, Higginbotham T, Price A, Berman K, Hosford L, Katcher PM, Ozanne E, Perzan K, Hur C. Preference of endoscopic ablation over medical prevention of esophageal adenocarcinoma by patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2015 Jan; 13(1):84-90. PMID: 24681073; PMCID: PMC4227952.
    24. O'Donoghue C, Eklund M, Ozanne EM, Esserman LJ. Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. Ann Intern Med. 2014 Feb 04; 160(3):145. PMID: 24658691; PMCID: PMC4142190.
    25. Walsh T, Barr PJ, Thompson R, Ozanne E, O'Neill C, Elwyn G. Undetermined impact of patient decision support interventions on healthcare costs and savings: systematic review. BMJ. 2014 Jan 23; 348:g188. PMID: 24458654; PMCID: PMC3900320.
    26. Ozanne EM, Howe R, Omer Z, Esserman LJ. Development of a personalized decision aid for breast cancer risk reduction and management. BMC Med Inform Decis Mak. 2014 Jan 14; 14:4. PMID: 24422989; PMCID: PMC3899602.
    27. Barr PJ, Thompson R, Walsh T, Grande SW, Ozanne EM, Elwyn G. The psychometric properties of CollaboRATE: a fast and frugal patient-reported measure of the shared decision-making process. J Med Internet Res. 2014 Jan 03; 16(1):e2. PMID: 24389354; PMCID: PMC3906697.
    28. Bravo C, O'Donoghue C, Kaplan CP, Luce J, Ozanne E. Can mHealth Improve Risk Assessment in Underserved Populations? Acceptability of a Breast Health Questionnaire App in Ethnically Diverse, Older, Low-Income Women. J Health Dispar Res Pract. 2014; 7(4). PMID: 25705576.
      View in: PubMed
    29. Fehniger J, Livaudais-Toman J, Karliner L, Kerlikowske K, Tice JA, Quinn J, Ozanne E, Kaplan CP. Perceived versus objective breast cancer risk in diverse women. J Womens Health (Larchmt). 2014 May; 23(5):420-7. PMID: 24372085; PMCID: PMC4011422.
    30. Alvarado MD, Conolly J, Park C, Sakata T, Mohan AJ, Harrison BL, Hayes M, Esserman LJ, Ozanne EM. Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery. Breast Cancer Res Treat. 2014 Jan; 143(1):135-40. PMID: 24292868.
      View in: PubMed
    31. Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PK, King J, Lawson ML, Linder SK, Lipkus I, Ozanne E, Peters E, Timmermans D, Woloshin S. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Med Inform Decis Mak. 2013; 13 Suppl 2:S7. PMID: 24625237; PMCID: PMC4045391.
    32. Abhyankar P, Volk RJ, Blumenthal-Barby J, Bravo P, Buchholz A, Ozanne E, Vidal DC, Col N, Stalmeier P. Balancing the presentation of information and options in patient decision aids: an updated review. BMC Med Inform Decis Mak. 2013; 13 Suppl 2:S6. PMID: 24625214; PMCID: PMC4044010.
    33. Omer ZB, Hwang ES, Esserman LJ, Howe R, Ozanne EM. Impact of ductal carcinoma in situ terminology on patient treatment preferences. JAMA Intern Med. 2013 Oct 28; 173(19):1830-1. PMID: 23978843.
      View in: PubMed
    34. Alvarado MD, Mohan AJ, Esserman LJ, Park CC, Harrison BL, Howe RJ, Thorsen C, Ozanne EM. Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer. Ann Surg Oncol. 2013 Sep; 20(9):2873-80. PMID: 23812769.
      View in: PubMed
    35. Elwyn G, Barr PJ, Grande SW, Thompson R, Walsh T, Ozanne EM. Developing CollaboRATE: a fast and frugal patient-reported measure of shared decision making in clinical encounters. Patient Educ Couns. 2013 Oct; 93(1):102-7. PMID: 23768763.
      View in: PubMed
    36. Soeteman DI, Stout NK, Ozanne EM, Greenberg C, Hassett MJ, Schrag D, Punglia RS. Modeling the effectiveness of initial management strategies for ductal carcinoma in situ. J Natl Cancer Inst. 2013 Jun 05; 105(11):774-81. PMID: 23644480; PMCID: PMC3776282.
    37. Esserman L, Ozanne E, van't Veer L. Will early detection for breast cancer ever work? Clin Chem. 2013 Jan; 59(1):190-3. PMID: 23193061.
      View in: PubMed
    38. Ozanne EM, Drohan B, Bosinoff P, Semine A, Jellinek M, Cronin C, Millham F, Dowd D, Rourke T, Block C, Hughes KS. Which risk model to use? Clinical implications of the ACS MRI screening guidelines. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):146-9. PMID: 23093547.
      View in: PubMed
    39. Ozanne EM, O'Connell A, Bouzan C, Bosinoff P, Rourke T, Dowd D, Drohan B, Millham F, Griffin P, Halpern EF, Semine A, Hughes KS. Bias in the reporting of family history: implications for clinical care. J Genet Couns. 2012 Aug; 21(4):547-56. PMID: 22237666.
      View in: PubMed
    40. Alvarado M, Ozanne E, Esserman L. Overdiagnosis and overtreatment of breast cancer. Am Soc Clin Oncol Educ Book. 2012; e40-5. PMID: 24451829.
      View in: PubMed
    41. Campbell S, Stowe K, Ozanne EM. Interprofessional practice and decision support: an organizational framework applied to a mental health setting. J Interprof Care. 2011 Nov; 25(6):423-7. PMID: 22011027.
      View in: PubMed
    42. Lowry KP, Lee JM, Kong CY, McMahon PM, Gilmore ME, Cott Chubiz JE, Pisano ED, Gatsonis C, Ryan PD, Ozanne EM, Gazelle GS. Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis. Cancer. 2012 Apr 15; 118(8):2021-30. PMID: 21935911; PMCID: PMC3245774.
    43. Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, Chung RE, Tandon VJ, Park JW, Baehner FL, Kreps S, Tutt AN, Gillett CE, Benz CC. Biologic markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res Treat. 2011 Sep; 129(2):607-16. PMID: 21597921; PMCID: PMC4324750.
    44. Ozanne EM, Shieh Y, Barnes J, Bouzan C, Hwang ES, Esserman LJ. Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat. 2011 Aug; 129(1):165-73. PMID: 21390494.
      View in: PubMed
    45. Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS. Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology. 2010 Mar; 254(3):793-800. PMID: 20177093; PMCID: PMC2826703.
    46. Ozanne EM, Wittenberg E, Garber JE, Weeks JC. Breast cancer prevention: patient decision making and risk communication in the high risk setting. Breast J. 2010 Jan-Feb; 16(1):38-47. PMID: 19889168.
      View in: PubMed
    47. Drohan B, Ozanne EM, Hughes KS. Electronic health records and the management of women at high risk of hereditary breast and ovarian cancer. Breast J. 2009 Sep-Oct; 15 Suppl 1:S46-55. PMID: 19775330.
      View in: PubMed
    48. Sepucha K, Ozanne EM. How to define and measure concordance between patients' preferences and medical treatments: A systematic review of approaches and recommendations for standardization. Patient Educ Couns. 2010 Jan; 78(1):12-23. PMID: 19570647.
      View in: PubMed
    49. Ozanne EM, Partridge A, Moy B, Ellis KJ, Sepucha KR. Doctor-patient communication about advance directives in metastatic breast cancer. J Palliat Med. 2009 Jun; 12(6):547-53. PMID: 19508141.
      View in: PubMed
    50. Sepucha KR, Ozanne EM, Partridge AH, Moy B. Is there a role for decision aids in advanced breast cancer? Med Decis Making. 2009 Jul-Aug; 29(4):475-82. PMID: 19329775.
      View in: PubMed
    51. Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, West DW, Satariano WA, Liebman M, Esserman L. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer. 2009 Mar 01; 124(5):1213-9. PMID: 19058216.
      View in: PubMed
    52. Ozanne EM, Loberg A, Hughes S, Lawrence C, Drohan B, Semine A, Jellinek M, Cronin C, Milham F, Dowd D, Block C, Lockhart D, Sharko J, Grinstein G, Hughes KS. Identification and management of women at high risk for hereditary breast/ovarian cancer syndrome. Breast J. 2009 Mar-Apr; 15(2):155-62. PMID: 19292801.
      View in: PubMed
    53. Hur C, Broughton DE, Kong CY, Ozanne EM, Richards EB, Truong T, Gazelle GS. Patient preferences for the chemoprevention of colorectal cancer. Dig Dis Sci. 2009 Oct; 54(10):2207-14. PMID: 19057995; PMCID: PMC3737565.
    54. Ozanne EM, Braithwaite D, Sepucha K, Moore D, Esserman L, Belkora J. Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model. J Clin Oncol. 2009 Jan 10; 27(2):214-9. PMID: 19047286.
      View in: PubMed
    55. Pandharipande PV, Harisinghani MG, Ozanne EM, Specht MC, Hur C, Lee JM, Gazelle GS. Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis. AJR Am J Roentgenol. 2008 Nov; 191(5):1308-19. PMID: 18941062.
      View in: PubMed
    56. Hur C, Broughton DE, Ozanne E, Yachimski P, Nishioka NS, Gazelle GS. Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol. 2008 Oct; 103(10):2432-42. PMID: 18775019; PMCID: PMC3736801.
    57. Silvia KA, Ozanne EM, Sepucha KR. Implementing breast cancer decision aids in community sites: barriers and resources. Health Expect. 2008 Mar; 11(1):46-53. PMID: 18275401.
      View in: PubMed
    58. Esserman LJ, Shieh Y, Park JW, Ozanne EM. A role for biomarkers in the screening and diagnosis of breast cancer in younger women. Expert Rev Mol Diagn. 2007 Sep; 7(5):533-44. PMID: 17892362.
      View in: PubMed
    59. Ozanne EM, Annis C, Adduci K, Showstack J, Esserman L. Pilot trial of a computerized decision aid for breast cancer prevention. Breast J. 2007 Mar-Apr; 13(2):147-54. PMID: 17319855.
      View in: PubMed
    60. Sepucha K, Ozanne E, Mulley AG. Doing the right thing: systems support for decision quality in cancer care. Ann Behav Med. 2006 Dec; 32(3):172-8. PMID: 17107289.
      View in: PubMed
    61. Sepucha K, Ozanne E, Silvia K, Partridge A, Mulley AG. An approach to measuring the quality of breast cancer decisions. Patient Educ Couns. 2007 Feb; 65(2):261-9. PMID: 17023138.
      View in: PubMed
    62. Ozanne EM, Klemp JR, Esserman LJ. Breast cancer risk assessment and prevention: a framework for shared decision-making consultations. Breast J. 2006 Mar-Apr; 12(2):103-13. PMID: 16509834.
      View in: PubMed
    63. Esserman LJ, Ozanne EM, Dowsett M, Slingerland JM. Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis. Breast Cancer Res. 2005; 7(6):R1153-8. PMID: 16457695; PMCID: PMC1410777.
    64. Ozanne EM, Esserman LJ. Evaluation of breast cancer risk assessment techniques: a cost-effectiveness analysis. Cancer Epidemiol Biomarkers Prev. 2004 Dec; 13(12):2043-52. PMID: 15598759.
      View in: PubMed
    65. Esserman L, Sepucha K, Ozanne E, Hwang ES. Applying the neoadjuvant paradigm to ductal carcinoma in situ. Ann Surg Oncol. 2004 Jan; 11(1 Suppl):28S-36S. PMID: 15015707.
      View in: PubMed